Denes MARTON,Steven R. BAILEY,Christopher E. BANAS,Christoper T. BOYLE
申请号：
US14825526
公开号：
US20150342761A1
申请日:
2015.08.13
申请国别(地区):
US
年份:
2015
代理人:
摘要：
The drug eluting device consists of an implantable structural element for in vivo controlled delivery of bioactive active agents to a situs in a body. The implantable structural element may be configured as an implantable prosthesis, such as an endoluminal stent, cardiac valve, osteal implant or the like, which serves a dual function of being prosthetic and a carrier for a bioactive agent. Control over elution of the bioactive agents occurs through a plurality of cantilever-like cover members which prevent drug elution until an endogenous or exogenous stimulus causes the cover members to open and permit drug elution.
